{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:21:04Z","timestamp":1775060464604,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,11]]},"DOI":"10.7759\/cureus.75560","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T02:35:37Z","timestamp":1733970937000},"source":"Crossref","is-referenced-by-count":1,"title":["Hypothermia, Hallucinations, and Atrial Fibrillation Secondary to Diffuse Large B-cell Lymphoma"],"prefix":"10.7759","author":[{"given":"Taner B","family":"Celebi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Shamulzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Muraca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Santoriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li S","year":"2018","unstructured":"Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018, 50:74-87. 10.1016\/j.pathol.2017.09.006","journal-title":"Pathology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.12.009","article-title":"Diffuse large B-cell lymphoma","volume":"87","author":"Martelli M","year":"2013","unstructured":"Martelli M, Ferreri AJ, Agostinelli C, Di Rocco A, Pfreundschuh M, Pileri SA. Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol. 2013, 87:146-71. 10.1016\/j.critrevonc.2012.12.009","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/medsci9010005","article-title":"Epidemiology of non-Hodgkin's lymphoma","volume":"9","author":"Thandra KC","year":"2021","unstructured":"Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Epidemiology of non-Hodgkin's lymphoma. Med Sci (Basel). 2021, 9:10.3390\/medsci9010005","journal-title":"Med Sci (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-024-00265-8","article-title":"Epidemiology and real-world treatment of incident diffuse large B-cell lymphoma (DLBCL): a German claims data analysis","volume":"12","author":"Pacis S","year":"2024","unstructured":"Pacis S, Bolzani A, Heuck A, et al.. Epidemiology and real-world treatment of incident diffuse large B-cell lymphoma (DLBCL): a German claims data analysis. Oncol Ther. 2024, 12:293-309. 10.1007\/s40487-024-00265-8","journal-title":"Oncol Ther"},{"key":"ref5","unstructured":"Surveillance, Epidemiology, and End Results Program. (2024). https.\/\/seer.cancer.gov\/statfacts\/html\/dlbcl.html."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01962-5","article-title":"Correction: \"The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms\" Leukemia. 2022 Jul;36(7):1720-1748","volume":"37","author":"Alaggio R","year":"2023","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. Correction: \"The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms\" Leukemia. 2022 Jul;36(7):1720-1748. Leukemia. 2023, 37:1944-51. 10.1038\/s41375-023-01962-5","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-577189","article-title":"Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity","volume":"125","author":"Sehn LH","year":"2015","unstructured":"Sehn LH, Gascoyne RD. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. Blood. 2015, 125:22-32. 10.1182\/blood-2014-05-577189","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1124360","article-title":"Molecular classification and therapeutics in diffuse large B-cell lymphoma","volume":"10","author":"Shimkus G","year":"2023","unstructured":"Shimkus G, Nonaka T. Molecular classification and therapeutics in diffuse large B-cell lymphoma. Front Mol Biosci. 2023, 10:1124360. 10.3389\/fmolb.2023.1124360","journal-title":"Front Mol Biosci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma","volume":"21","author":"Wilson WH","year":"2015","unstructured":"Wilson WH, Young RM, Schmitz R, et al.. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat Med. 2015, 21:922-6. 10.1038\/nm.3884","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2040620711419001","article-title":"The molecular biology of diffuse large B-cell lymphoma","volume":"2","author":"Frick M","year":"2011","unstructured":"Frick M, D\u00f6rken B, Lenz G. The molecular biology of diffuse large B-cell lymphoma. Ther Adv Hematol. 2011, 2:369-79. 10.1177\/2040620711419001","journal-title":"Ther Adv Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald A","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, et al.. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002, 346:1937-47. 10.1056\/NEJMoa012914","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115304","article-title":"Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma","volume":"386","author":"Tilly H","year":"2022","unstructured":"Tilly H, Morschhauser F, Sehn LH, et al.. Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma. N Engl J Med. 2022, 386:351-63. 10.1056\/NEJMoa2115304","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","year":"1993","unstructured":"A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993, 329.987-94. 10.1056\/NEJM199309303291402","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson BD","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014, 32:3059-68. 10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"ref15","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken MM","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, et al.. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5:649-55.","journal-title":"Am J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/316810-hypothermia-hallucinations-and-atrial-fibrillation-secondary-to-diffuse-large-b-cell-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T02:35:41Z","timestamp":1733970941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/316810-hypothermia-hallucinations-and-atrial-fibrillation-secondary-to-diffuse-large-b-cell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.75560","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,11]]}}}